http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-006448-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b9036c33bbe3f4ea428655b76200f7c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4738 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
| filingDate | 2002-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0d6e8cae9a8139f671f871b33c0a8fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ec45a4565e75cd2948b5e40fccc7adc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e60071fe50fbcebdc7be5ba6ef52a4c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d42d63f0496179ccf15d8d59eec03b8a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c297d3e223a1bac8f96fa7b3ad1e35fd |
| publicationDate | 2005-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-006448-B1 |
| titleOfInvention | DRUG FOR THE TREATMENT OF THE SYMPTOMS OF THE INFLAMMATED URINARY BUBBLE, ASSOCIATED WITH BENIGNAL HYPERPLASIA OF THE PROSTATE GLAND |
| abstract | The present invention relates to a therapeutic agent for treating symptoms of irritated bladder associated with benign prostatic hyperplasia, comprising as an active ingredient a tricyclic compound represented by the formula (I) wherein R 1 is a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkoxy or halogen; X-X-X is CR = CR-CR = CR, N (O) = CR-CR = CR, CR = CR-N (O) -CR, CR = CR-CR = N (O), CR = CR -O, CR = CR-S, O-CR = CR, S-CR = CR or O-CR = N; Y is —CHS—, —CHSO—, —CHSO—, —CHO—, —CH = CH—, - (CH) -, —SCH—, —SOCH—, —SOCH— or —OCH—; R represents an atom hydrogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkenyl, substituted or unsubstituted lower alkoxy, amino, monosubstituted (substituted or unsubstituted lower alkyl) amino, disubstituted (substituted or unsubstituted lower alkyl) amino, substituted or unsubstituted aryl, substituted or unsubstituted lower heteroaryl, substituted or unsubstituted aralkylamino, substituted or unsubstituted arylamino, or for a substituted or unsubstituted heteroalicyclic group, or a pharmaceutically acceptable salt thereof. |
| priorityDate | 2001-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 88.